Skip to main content
. 2016 Oct 11;7(45):73935–73944. doi: 10.18632/oncotarget.12558

Table 2. The result of meta-analysis for various genotype models.

SNP Covariates Variables No. of studies Sample size (case/control) Allele Homozygous Heterozygous Dominant Recessive
OR (95%CI) Ph/I2 OR (95%CI) Ph/I2 OR (95%CI) Ph/I2 OR (95%CI) Ph/I2 OR (95%CI) Ph/I2
rs4245739 A/C All 16 19950/49914 0.848 (0.765-0.941) <0.001/87.2% 1.002 (0.866-1.159) 0.008/52.3% 0.831 (0.735-0.939) <0.001/85.0% 0.823 (0.727-0.932) <0.001/86.8% 0.981 (0.394-2.444) <0.001/99.1%
Ethnicity Asian 8 3416/4483 0.561 (0.439-0.718) 0.001/71.1% 0.782 (0.536-1.141) 0.910/0.0% 0.547 (0.428-0.698) 0.007/64.0% 0.544 (0.428-0.692) 0.007/64.1% 0.806 (0.562-1.156) 0.918/0.0%
Caucasian 8 16534/45431 1.022 (0.948-1.101) <0.001/78.6% 1.028 (0.875-1.208) 0.001/71.7% 1.037 (0.960-1.119) 0.060/64.3% 1.034 (0.949-1.126) <0.001/74.3% 1.304(0.394-4.316) <0.001/99.6%
Cancer type BC 3 9329/44721 0.766 (0.573-1.025) <0.001/94.3% 0.937 (0.545-1.608) <0.001/83.3% 0.776 (0.571-1.055) <0.001/92.1% 0.759 (0.547-1.054) <0.001/93.7% 0.945 (0.590-1.512) 0.002/79.3%
LC 3 1128/1150 0.607 (0.308-1.194) <0.001/90.4% 1.075 (0.844-1.370) 0.762/0.0% 0.584 (0.288-1.185) <0.001/90.0% 0.585 (0.839-1.068) <0.001/90.5% 1.067 (0.843-1.352) 0.814/0.0%
ESCC 2 1851/4787 0.616 (0.478-0.793) 0.438/0.0% 1.197 (0.318-4.500) 0.759/0.0% 0.565 (0.431-0.741) 0.484/0.0% 0.580 (0.445-0.757) 0.464/0.0% 1.273 (0.339-4.785) 0.763/0.0%
OC 2 1539/2023 1.065 (0.958-1.183) 0.767/0.0% 1.009 (0.778-1.308) 0.641/0.0% 1.141 (0.993-1.312) 0.917/0.0% 1.119 (0.980-1.278) 0.841/0.0% 0.954 (0.741-1.229) 0.653/0.0%
Other 6 6103/8314 0.960 (0.878-1.049) 0.080/52.1% 0.964 (0.841-1.105) 0.917/0.0% 0.949 (0.835-1.079) 0.044/59.1% 0.947 (0.839-1.068) 0.049/57.9% 0.972 (0.851-1.110) 0.912/0.0%
Source of controls HB 2 622/646 0.935 (0.790-1.106) 0.648/0.0% 0.803 (0.547-1.180) 0.985/0.0% 0.999 (0.791-1.262) 0.598/0.0% 0.960 (0.769-1.199) 0.588/0.0% 0.812 (0.563-1.170) 0.895 /0.0%
PB 13 12816/18898 0.803 (0.714-0.903) <0.001/83.0% 0.969 (0.874-1.075) 0.869/0.0% 0.768 (0.664-0.890) <0.001/83.4% 0.768 (0.667-0.886) <0.001/83.6% 0.967 (0.874-1.069) 0.906 /0.0%
Mixed 1 6512/41451 1.159 (1.112-1.207) 1.355 (1.229-1.494) 1.148 (1.087-1.213) 1.180 (1.120-1.243) 1.277 (1.162-1.405)
rs11801299 G/A All (Caucasian) 2 1446/1400 1.715 (0.531-5.545) <0.001/98.5% 3.549 (0.302-41.765) <0.001/97.2% 1.583 (0.523-4.794) <0.001/97.1% 1.816 (0.471-7.003) <0.001/98.2% 2.817 (0.401-19.803) <0.001/95.6%
rs1380576 C/G All 3 2088/2120 1.018 (0.931-1.114) 0.393/0.0% 1.002 (0.831-1.208) 0.558/0.0% 1.094 (0.958-1.250) 0.918/0.0% 1.070 (0.944-1.212) 0.771/0.0% 0.943 (0.797-1.116) 0.461/0.0%
Ethnicity Asian 1 642/720 0.939 (0.807-1.091) 0.895 (0.676-1.184) 1.093 (0.846-1.411) 1.008 (0.798-1.273) 0.849 (0.671-1.075)
Caucasian 2 1446/1400 1.065 (0.953-1.191) 0.735/0.0% 1.098 (0.853-1.413) 0.850/0.0% 1.095 (0.937-1.279) 0.680/0.0% 1.096 (0.945-1.270) 0.681/0.0% 1.052 (0.827-1.339) 0.948/0.0%
rs10900598 G/T All (Caucasian) 2 1446/1400 0.530 (0.163-1.729) <0.001/98.7% 0.253 (0.019-3.363) <0.001/98.2% 0.559 (0.193-1.615) <0.001/96.6% 0.481 (0.126-1.832) <0.001/98.1% 0.341 (0.043-2.713) <0.001/97.4%
rs1563828 C/T All 3 384/1100 0.909 (0.738-1.120) 0.750/0.0% 0.768 (0.474-1.244) 0.642/0.0% 0.972 (0.728-1.297) 0.867/0.0% 0.929 (0.706-1.223) 0.825/0.0% 0.776 (0.490-1.229) 0.657/0.0%
Ethnicity Asian 2 334/301 0.948 (0.750-1.199) 0.928/0.0% 0.859 (0.510-1.445) 0.921/0.0% 0.999 (0.718-1.392) 0.678/0.0% 0.969 (0.708-1.325) 0.764/0.0% 0.855 (0.522-1.402) 0.804/0.0%
Caucasian 1 50/799 0.776 (0.488-1.236) 0.412 (0.096-1.770) 0.890 (0.494-1.603) 0.808 (0.456-1.434) 0.434 (0.103-1.823)
Cancer type (Source of controls) BC (HB) 1 124/101 0.962(0.651-1.421) 0.830(0.358-1.926) 1.100(0.627-1.932) 1.034(0.608-1.757) 0.791(0.358-1.747)
Other (PB) 2 260/999 0.889(0.695-1.138) 0.493/0.0% 0.740(0.411-1.335) 0.350/0.0% 0.930(0.664-1.301) 0.859/0.0% 0.893(0.647-1.232) 0.680/0.0% 0.768(0.437-1.352) 0.358/0.0%